The Committee to Restore Nymox Shareholder Value Soundly Rebuts Injurious Allegations Made by Nymox Pharmaceutical Corp Current Management

CARSON CITY, Nev. & LONDON--(BUSINESS WIRE)--The Committee to Restore Nymox Shareholder Value, LLC (CRNSV), with a goal to recover shareholder value in NYMOX PHARMACEUTICAL CORP ("NYMX-Q") by reestablishing a proposed partnership with a highly respected, global specialty pharmacy and healthcare solutions company, today resolutely refutes all allegations made in a press release by current Nymox leadership. Chris Riley, one of the founding members of CRNSV, says, “The fallacious statements in the